Patent · US Active

Methods for treatment of cancer

US9101584B2 · kind B2 · utility

165Cited by
27References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2014
Grant dateAug 11, 2015
Priority date
Expiry dateDec 12, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/15071
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for treating cancer in a human. The invention includes relates to administering a genetically modified T cell to express a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.